Cargando…
Transcription Factor DLX5 As a New Target for Promising Antitumor Agents
The crystal structure of the human transcription factor DLX5 has been used for the screening of a library consisting of 10(6 )compounds by the molecular docking technique.In vitro testsof the 14 top-rated ligands showed that compound Q12 displays the best ability to inhibit the proliferation ofDlx5...
Autores principales: | Timakhov, R.A., Fedichev, P.O., Vinnik, A.A., Testa, J.R., Favorova, O.O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
A.I. Gordeyev
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3347611/ https://www.ncbi.nlm.nih.gov/pubmed/22649693 |
Ejemplares similares
-
Structure-based drug design of a new chemical class of small molecules active against influenza A nucleoprotein in vitro and in vivo
por: Fedichev, Peter, et al.
Publicado: (2011) -
DLX Genes: Roles in Development and Cancer
por: Tan, Yinfei, et al.
Publicado: (2021) -
Dlx5 and Dlx6 can antagonize cell division at the G(1)/S checkpoint
por: MacKenzie, Rachel K., et al.
Publicado: (2019) -
DLX5 expression is monoallelic and Dlx5 is up-regulated in the Mecp2-null frontal cortex
por: Miyano, Masaru, et al.
Publicado: (2008) -
A Polygenic Approach to the Study
of Polygenic
Diseases
por: Lvovs, D., et al.
Publicado: (2012)